Year: 2012
Type: article
Abstract: Although a substantial amount of information about clinical pulmonary arterial hypertension (PAH) has accumulated over the past decades, there remains a need for our understanding to keep pace with the evolving milieu in which management of patients with PAH occurs. The goal of the Patient Registry for the Characterization of Primary Pulmonary Hypertension, initiated in 1981 under the sponsorship of the National Institutes of Health (NIH), was to elucidate the clinical characteristics and natural history of patients with primary pulmonary hypertension (now called idiopathic PAH; IPAH). The practical aims of the registry were to promote understanding about potential causes, facilitate early and accurate diagnosis, and develop more effective treatment strategies [1]. Analysis of the 187 patients who were enrolled from 1981 to 1985 laid a foundation of knowledge which provided the impetus for the creation of appropriate diagnostic algorithms, predictive models and the development of more effective drugs. Indeed, the importance of this undertaking has been demonstrated by its use as a basis of comparison when judging the efficacy of various treatment modalities. However, largely as a result of these advances, as well as the recognition (articulated in subsequent international symposia [2–4]) that pulmonary vascular disease is a factor in a broader spectrum of clinical contexts, the pulmonary hypertension (PH) medical community has perceived that the current understanding of this constellation of pulmonary vasculopathies requires updating and expansion.
While randomised trials remain the standard for evaluating the safety and efficacy of new drugs and treatment regimens, the structured design of clinical trials is not optimal for evaluating a range of other scientific objectives. Observational studies, when consecutive enrolment is employed, do not suffer from the selection bias that exists in almost all clinical trials, allowing for a more accurate and generalisable assessment of demographics, …
Source: European Respiratory Review
Authors: M.D. McGoon, D.P. Miller
Institution: Mayo Clinic
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
Funders: Massachusetts General Hospital, Vanderbilt University, Wayne State University, University of Pennsylvania, Ohio State University, Texas Children's Hospital, University of Minnesota, School of Medicine, Boston University, Cleveland Clinic, Cleveland Clinic Foundation, University of Utah, Johns Hopkins University, University of Pittsburgh, University of Rochester, University of South Carolina, Virginia Commonwealth University, Children’s Hospital of Wisconsin Research Institute, Vanderbilt University Medical Center, Ochsner Health, University of California, San Diego, University of California, San Francisco, Medical Center, University of Rochester, Actelion Pharmaceuticals
OpenAlex ID: W2106446798
